Hunan Hansen Pharmaceutical Co Ltd Financial Flexibility Index
Hunan Hansen Pharmaceutical Co Ltd financial flexibility index. Hunan Hansen Pharmaceutical Co Ltd (002412) has a Financial Flexibility Index of 0.19x as of September 2025. Free cash flow of CN¥56.32 Million (operating CF CN¥52.51 Million minus capex CN¥3.82 Million) represents 0% of total liabilities (CN¥301.66 Million). See free cash flow generation of Hunan Hansen Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
Financial flexibility index of Hunan Hansen Pharmaceutical Co Ltd from 2007 to 2025. Historical Financial Flexibility Index trend for Hunan Hansen Pharmaceutical Co Ltd across 19 annual periods. Check Hunan Hansen Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Hunan Hansen Pharmaceutical Co Ltd Financial Flexibility Index by Year (2007–2025)
Hunan Hansen Pharmaceutical Co Ltd financial flexibility index by year from 2007 to 2025. Year-by-year free cash flow to debt coverage for Hunan Hansen Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Hunan Hansen Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥256.48 Million | CN¥245.38 Million | CN¥312.15 Million | ▲ +98.4% |
| 2024 | 0.41x | CN¥142.42 Million | CN¥130.78 Million | CN¥343.85 Million | ▼ -14.3% |
| 2023 | 0.48x | CN¥180.42 Million | CN¥160.95 Million | CN¥373.46 Million | ▲ +23.4% |
| 2022 | 0.39x | CN¥155.31 Million | CN¥143.81 Million | CN¥396.81 Million | ▼ -67.3% |
| 2021 | 1.20x | CN¥441.87 Million | CN¥212.54 Million | CN¥368.99 Million | ▲ +20.8% |
| 2020 | 0.99x | CN¥291.27 Million | CN¥162.19 Million | CN¥293.92 Million | ▲ +74.2% |
| 2019 | 0.57x | CN¥200.82 Million | CN¥165.11 Million | CN¥352.93 Million | ▼ -12.2% |
| 2018 | 0.65x | CN¥282.05 Million | CN¥217.52 Million | CN¥435.02 Million | ▲ +98.2% |
| 2017 | 0.33x | CN¥157.38 Million | CN¥107.18 Million | CN¥481.18 Million | ▼ -34.0% |
| 2016 | 0.50x | CN¥206.07 Million | CN¥161.16 Million | CN¥415.88 Million | ▼ -54.9% |
| 2015 | 1.10x | CN¥139.46 Million | CN¥63.57 Million | CN¥126.83 Million | ▲ +48.6% |
| 2014 | 0.74x | CN¥158.80 Million | CN¥85.05 Million | CN¥214.59 Million | ▼ -14.0% |
| 2013 | 0.86x | CN¥184.53 Million | CN¥76.09 Million | CN¥214.46 Million | ▼ -70.0% |
| 2012 | 2.87x | CN¥220.10 Million | CN¥100.23 Million | CN¥76.76 Million | ▲ +71.7% |
| 2011 | 1.67x | CN¥91.74 Million | CN¥53.84 Million | CN¥54.95 Million | ▲ +231.3% |
| 2010 | 0.50x | CN¥24.81 Million | CN¥21.24 Million | CN¥49.23 Million | ▼ -44.6% |
| 2009 | 0.91x | CN¥61.56 Million | CN¥41.02 Million | CN¥67.69 Million | ▲ +63.9% |
| 2008 | 0.55x | CN¥46.98 Million | CN¥33.94 Million | CN¥84.67 Million | ▼ -12.6% |
| 2007 | 0.64x | CN¥54.93 Million | CN¥37.75 Million | CN¥86.49 Million | — |